| IOL Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524164 |
NSE Symbol : IOLCP |
P/E(TTM) : 21.35 |
|
ISIN Demat : INE485C01029 |
Div & Yield% : 0.95 |
EPS(TTM) : 3.96 |
|
Book Value(₹) : 59.66 |
Market Cap(₹Cr) : 2,481.19 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 567.53 | 551.69 | 527.78 | 523.30 | 525.75 | 502.38 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 567.53 | 551.69 | 527.78 | 523.30 | 525.75 | 502.38 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.88 | 7.37 | 4.52 | 4.07 | 6.43 | 7.38 |
| Total Income | 574.41 | 559.06 | 532.30 | 527.37 | 532.18 | 509.76 |
| Total Expenditure | 510.43 | 489.54 | 464.84 | 476.43 | 484.19 | 451.58 |
| PBIDT | 63.98 | 69.52 | 67.46 | 50.94 | 47.99 | 58.18 |
| Interest | 3.48 | 4.23 | 4.03 | 4.46 | 4.12 | 2.15 |
| PBDT | 60.50 | 65.29 | 63.43 | 46.48 | 43.87 | 56.03 |
| Depreciation | 19.98 | 19.75 | 18.53 | 18.66 | 17.93 | 16.80 |
| Tax | 8.96 | 10.49 | 7.06 | 4.34 | 4.57 | 8.77 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.56 | 1.09 | 6.22 | 2.93 | 2.22 | 0.78 |
| Reported Profit After Tax | 30.00 | 33.96 | 31.62 | 20.55 | 19.15 | 29.68 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 30.00 | 33.96 | 31.62 | 20.55 | 19.15 | 29.68 |
| EPS (Unit Curr.) | 1.02 | 1.16 | 5.38 | 3.50 | 3.26 | 5.06 |
| EPS (Adj) (Unit Curr.) | 1.02 | 1.16 | 5.38 | 0.70 | 0.65 | 1.01 |
| Calculated EPS (Unit Curr.) | 1.02 | 1.16 | 5.39 | 3.50 | 3.26 | 5.06 |
| Calculated EPS (Adj) (Unit Curr.) | 1.02 | 1.16 | 5.39 | 0.70 | 0.65 | 1.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.09 | 4.63 | 21.54 | 14.00 | 13.05 | 20.22 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.09 | 4.63 | 21.54 | 2.80 | 2.61 | 4.04 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 40.00 | 0.00 | 0.00 |
| Equity | 58.71 | 58.71 | 58.71 | 58.71 | 58.71 | 58.71 |
| Reserve & Surplus | 1,692.41 | 1,662.02 | 1,628.70 | 1,620.54 | 1,600.10 | 1,580.87 |
| Face Value | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 11.27 | 12.60 | 12.78 | 9.73 | 9.13 | 11.58 |
| PBDTM(%) | 10.66 | 11.83 | 12.02 | 8.88 | 8.34 | 11.15 |
| PATM(%) | 5.29 | 6.16 | 5.99 | 3.93 | 3.64 | 5.91 |